Lynch ST, Renard KB, Chaia AI, Cohen LJ, et al. Aripiprazole two-month long-acting injectable may increase time to readmission compared to aripiprazole one-month in patients with schizophrenia and schizoaffective disorder. Schizophr Res 2026;293:1-7.
PMID: 41875616